NRG Oncology Information




RTOG, NSABP and GOG Begin Integration into NRG Oncology

With the submission of the NRG Oncology grant proposal to the National Cancer Institute (NCI) on January 15, the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group (GOG) took the formal step toward becoming the cancer clinical cooperative group NRG Oncology. The three legacy groups will continue to carry out NCI supported trials as independent but collaborative entities through February 2014, with 96 total trials open for patient accrual and 68 trials in development. If all goes as planned, beginning in March 2014, NRG Oncology’s federal research activities will be managed under the auspices of the NRG Oncology Operations Center. The three current group chairs, Walter J. Curran, Jr., MD; Philip J. DiSaia, MD; and Norman Wolmark, MD, will serve as NRG Oncology principal investigators (PIs) and share equal responsibility for executing the group’s research program. The Newsletter, Scientific Structure Handout, and Leadership Roles Memo provide more details about our exciting new group.


NRG Oncology February 2014 Meeting Information


NRG Oncology Winter 2013 Newsletter

NRG Oncology Scientific Structure

NRG Oncology Leadership Roles

Plenary Session Slides January 2013 San Diego Semiannual Meeting